Shopping Cart 0
Cart Subtotal
AED 0

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Sanofi (SAN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sanofi is a healthcare company that researches, develops, manufactures and markets a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women's health; and vitamins, minerals and supplements. The R&D efforts of Sanofi include working on combination drugs to increase the effectiveness of treatments and advancing the formulation of new biologics to produce medicines with precision. It has operations across Europe, the Americas, Asia-Pacific, Africa and the Middle East. Sanofi is headquartered in Paris, France.

Sanofi Key Recent Developments

Mar 24,2019 Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit

Mar 01,2019 Pius S. Hornstein, PhD, appointed new country chair of Sanofi China

Feb 28,2019 The Jackson Laboratory signs a research agreement to identify new cancer therapeutic targets

Feb 27,2019 Top pharma executives testify before US Senate over high prices

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Sanofi-Key Facts

Sanofi-Key Employees

Sanofi-Key Employee Biographies

Sanofi-Major Products and Services

Sanofi-History

Sanofi-Company Statement

Sanofi-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Sanofi-Business Description

Business Segment: Consumer Health

Overview

Performance

Business Segment: Pharmaceuticals

Overview

Performance

Key Stats

Business Segment: Vaccines

Overview

Performance

Key Stats

Geographical Segment: Emerging Markets

Target Markets

Performance

Geographical Segment: Europe

Target Markets

Performance

Geographical Segment: Rest of the World

Target Markets

Performance

Geographical Segment: United States

Performance

R&D Overview

Sanofi-Corporate Strategy

Sanofi-SWOT Analysis

SWOT Analysis-Overview

Sanofi-Strengths

Sanofi-Weaknesses

Sanofi-Opportunities

Sanofi-Threats

Sanofi-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sanofi, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 24, 2019: Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit

Mar 01, 2019: Pius S. Hornstein, PhD, appointed new country chair of Sanofi China

Feb 28, 2019: The Jackson Laboratory signs a research agreement to identify new cancer therapeutic targets

Feb 27, 2019: Top pharma executives testify before US Senate over high prices

Feb 15, 2019: Hagens Berman: Judge Denies Insulin Makers' Motion to Dismiss Class-Action Lawsuit Regarding Skyrocketing Insulin Prices

Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer

Feb 07, 2019: Sanofi delivers 2018 business EPS growth of 5.1% at CER

Feb 07, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

Feb 06, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

Feb 06, 2019: Sanofi gets US okay for USD 270,000 blood disorder drug Cablivi

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sanofi, Performance Chart (2014-2018)

Sanofi, Ratio Charts

Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Sanofi, Key Facts

Sanofi, Key Employees

Sanofi, Key Employee Biographies

Sanofi, Major Products and Services

Sanofi, History

Sanofi, Subsidiaries

Sanofi, Joint Venture

Sanofi, Key Competitors

Sanofi, Ratios based on current share price

Sanofi, Annual Ratios

Sanofi, Annual Ratios (Cont...1)

Sanofi, Annual Ratios (Cont...2)

Sanofi, Interim Ratios

Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sanofi, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sanofi, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sanofi, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts